Company: INTS
Filing Date: 2025-04-22
Form Type: S-1
Source: 0001628280-25-018892
Chunk: 56

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-04-22
Form: S-1
Chunk 56
---
 of certain conditions.

We have agreed to indemnify the Placement Agents against specified liabilities, including liabilities under the Securities Act, and to contribute to payments the Placement Agents may be required to make in respect thereof.

#### Fees and Expenses
We have agreed to pay the Placement Agents an aggregate fee equal to seven percent (7.0%) of the purchase price paid by all purchasers in this offering. In addition, we have agreed to reimburse the Placement Agents for their legal fees in an amount up to $80,000 and non-accountable expenses of up to $25,000.

The following table shows the per share and total cash fees we will pay to the Placement Agents in connection with the sale of the securities pursuant to this prospectus.

|                                   |     | Per Share ofCommon StockandAccompanyingCommonWarrants |     | Per Pre-FundedWarrant andAccompanyingCommonWarrants |     | Total |
|:----------------------------------|:----|:------------------------------------------------------|:----|:----------------------------------------------------|:----|:------|
| Public offering price(1)          |     | $                                                     |     | $                                                   |     | $     |
| Placement Agents’ fees            |     | $                                                     |     | $                                                   |     | $     |
| Proceeds before expenses to us(2) |     | $                                                     |     | $                                                   |     | $     |

__________________

(1) The assumed combined public offering price is $1.88 per share of Common Stock and accompanying Common Warrants and $1.88 per Pre-Funded Warrant and accompanying Common Warrants.

(2) Does not include proceeds from the exercise of the Pre-Funded Warrants or Common Warrants in cash, if any.

We estimate the total expenses of this offering paid or payable by us, exclusive of the Placement Agents’ fee and reimbursements, will be approximately $160,000. After deducting the fees due to the Placement Agents and our estimated expenses in connection with this offering, we expect the net proceeds from this offering will be approximately $7.2 million (based on an assumed combined public offering price per share of Common Stock and accompanying Common Warrants of $1.88, which was the last reported sales price of the Common Stock on the Nasdaq Capital Market on April 21, 2025).

#### Lock-Up Agreements
Our directors and officers have entered into lock-up agreements. Under these agreements, these individuals agreed, subject to specified exceptions, not to sell or transfer any shares of